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AbstractThe invasive biopsy techniques ‘Radiodiagnosis’ utilize either metal based radiopharmaceuticals or biomolecule based radiopharmaceuticals. In the later case, the radioactive metal is attached by using bifunctional chelating agents, the organic chemical moiety which coordinates metals at one end and bear a reactive group on other side for conjugation to biomolecules. Thermodynamic and kinetic stability of metal complex along with reactivity of functional group to attach to biomolecule are central while choosing the efficient bifunctional chelating agents. Macrocyclic bifunctional chelating agents (BFCs) with their established stabilizing properties are in the forefront for radioimmunoapplications. Further introduction of rigidity in backbone of chelating moiety increases the kinetic inertness, even rigid acyclic ligand systems have shown increased kinetic inertness. In principle, rigid acyclic ligand systems, as exemplified by the classical trans-cyclohexylethylendiamine tetraacetic acid (CDTA) ligand, also provide enhanced kinetic inertness relative to flexible parent ligands. The rigid preorganized complexes are more stable in general. Rigidity of the BFCs could be increased by inclusion of cyclohexyl and benzyl moieties in the backbone. In this study macrocyclic BFCs with increase in rigidity for complex stability besides requisite flexibility for complexation along with variation in ring size and donor ligands group were aimed to study for radiodiagnostic applications. . The Bifunctional chelating agents {4,10-diamino-1,13-dithia-[2:3; 6:8 (3’-amino); 11:12] tribenzocyclopentadecane (5a), 4,10-diaino-1,13-dithia-[2:3; 6:8 (3’-amino); 11:12]tribenzo-cyclohexadecane (5b) and 4,10-diamino-16-oxa-1,13-ditha-[2:3; 6:8 (3’-amino); 11:12] tribenzocyclooctadecane (5c)} based on the Bis(2-aminophenyl thio) alkane moiety having benzyl group in backbone were designed and synthesized. Bifunctional chelating agents 5a-c were synthesized by macrocyclization of bis (2-aminophenyl thio) alkanes with 3,5-bis-bromomethylnitrobenzene followed by reduction of nitro group using Zn/NH2NH2. A varied general transformation was observed during the cyclization of bis(2-aminophenylthio)propane (and other 2-aminophenylthioalkanes) with bromoacetyl- bromide where the product obtained was 3-oxo-3,4-dihydro-2H-1,4-benzothiazine (1) instead of expected macrocycle (4,7-diamino-1,10-dithia-5-oxo-[2:3; 8:9]dibenzo-cyclotridecane. The bifunctional chelating agents (5a-c) were characterized on the basis of spectroscopic analysis (FT-IR NMR and mass spectra). Radiocomplexes formed by these chelating agents 5a-c with radioactive 99mTc were obtained in high yield. Among the three chelating agents used, 5c showed maximum complexation with 98% purity followed by 5b (92-94%) with lowest being of 5a (82%). 99mTc-5b and 99mTc-5c are stable in serum under physiological conditions. 
The blood clearance of complexes was slower, leaving 14% of activity in the blood after 8h. The bioconjugation of BFC 5b to monoclonal antibody anti-EGFr was done using 2-hydroxyacetaldehyde by Amadori rearrangement. The bioconjugate anti-EGFr-5b labeled with 99mTc showed high labeling with stability of radiobioconjugate as was observed with the BFC 5b. The EAT (Eherlic Ascite Tumor) developed in right thigh of mice was imaged using this conjugate under gamma camera which showed good localization of radiobioconjugate in tumor site. Further, the concept of pretargeting has been utilized for the enhancing the contrast (Signal to background radiation) in imaging of different tumors. The BFC-5b-c were conjugated with NHS ester of biotin to obtain Biotin-5b conjugate (B5bC) and Biotin-5c conjugate (B5cC). The radiolabeling procedure followed was essentially similar to that standardized for unconjugated chelating agents. 99mTc-5b-biotin (99mTcB5bC) was prepared with more than 95% labeling purity while 99mTc-5c-biotin (99mTc-B5cC) was obtained in more than 98% radiochemical purity. The uptake of radiopharmaceuticals in EAT (Ehrlich Ascite Tumors) cells was calculated as the ratio of the radiopharmaceutical/free 99mTcO4Na. The mean ratio of 99mTcB5bC/Na99mTcO4  was 50:1. EAT tumor generated in right thigh of mice was taken for evaluation in vivo. The avidin was injected subcutaneously followed by i.v. injection of 99mTc-B5bC through tail of tumor bearing mice. At the interval of 4 hours, major distribution in tumor was observed as indicated by biodistribution studies and in vivo images. This clearly contrasted with non-tumor site of left thigh where no or negligible radio activity was present and thus indicated the successful utilization of aromatic BFCs for scintigraphic applications.The last section “Synthesis of 3-Oxo-3,4-dihydro-2H-1,4-benzothiazine” describes a transformation observed during the synthesis of macrocyclic chelating agents. The varied transformation was observed during the cyclization of bis(2-aminophenylthio)propane with bromoacetylbromide where the product obtained was 3-oxo-3,4-dihydro-2H-1,4-benzothiazine (1) instead of expected macrocycle. Further evaluation with other 2-aminophenyl thioalkanes also gave the 1 as sole product. This thus established a general transformation of 2-aminophenylthioalkanes with bromoacetylbromide to form 3-oxo-3,4-dihydro-2H-1,4-benzothiazine (1) heterocycle.Novel bifunctional chelating agents (5a-c) bearing aromatic rigid backbone have been synthesized and characterized on the basis of spectroscopic techniques. These macrocyclic mutidentate chelating agents form stable complexes with 99mTc with high radiochemical purityA rapid and convenient synthetic methodology for the cyclocondensative transformation of various alkylsulfanylphenylamines with bromoacetyl bromide by supporting on KF-alumina in ionic liquids [bmim][Br] and [bmim][BF4] has been developed to obtain 3-oxo-1,4-benzothiazine in good yields. The product is easily obtained by extraction with ethyl acetate and concentrating under vacuum. Easy recovery of ionic liquid and use in consecutive reactions is also reported.A rapid and efficient synthesis of 7-substituted 3-oxo-1,4-benzothiazines from alkyl and arylalkylthioethers under solvent free conditions using microwave irradiation has been described.


